| Application no. and date | 20208043.8 (espacenet) (Federated) (European Patent Register), 20160612 | | Patent/reg. no. and date | DK/EP 3845557, 20230802 | | Publication date | 20210707 | | Priority no. and date | US 201562175003 P, 20150612 | | EP pub. no. and date |
EP 3845557 20210707 | | Effective date | | | Applicant/owner | Lentigen Technology, Inc., 910 Clopper Road, Suite 200S
Gaithersburg, MD 20878, US | | Applicant ref. no. | | | Inventor | DROPULIC, Boro, 12637 Golden Oak Drive
Ellicott City, MD 21042, US,
KRUEGER, Winfried, 3914 Decatur Avenue
Kensington, MD 20895, US,
SCHNEIDER, Dina, 7923 Inverness Ridge Road
Potomac, MD 20854, US,
ORENTAS, Rimas, 3601 Connecticut Avenue NW
Apt. 621
Washington, MD 20008, US | | Representative | | | Opponent | | | IPC Class | A61K 35/17 (2015.01) , A61K 38/17 (2006.01) , A61K 39/00 (2006.01) , A61P 35/00 (2006.01) , A61P 35/02 (2006.01) , A61P 7/00 (2006.01) , C12N 5/0783 (2010.01) , C07K 14/725 (2006.01) | | Title | METHOD TO TREAT CANCER WITH ENGINEERED T-CELLS | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
